Why the study?
Does the type of hemodialysis membrane or dialysate affect acute changes in plasma ICAM-1 and IL-1β levels in hemodialysis patients?
Does the type of hemodialysis membrane or dialysate affect acute changes in plasma ICAM-1 and IL-1β levels in hemodialysis patients?
Answers are grounded in this paper and cite their sources.
Bioincompatible hemodialysis membranes induce a significantly greater acute inflammatory response, as measured by IL-1β levels, compared to biocompatible membranes.
Fifty subjects: 20 controls and 30 hemodialysis patients were included in the study. The acute changes in plasma ICAM-1 and IL-1β levels immediately after dialysis were evaluated using two types of membranes and two types of dialysate. The predialysis ICAM-1 level in the whole patients was significantly higher than controls, while that of IL-1β was significantly lower. The postdialysis ICAM-1 showed insignificant higher level than the predialysis one, while that of IL-1β showed significant higher level than both the predialysis and control levels. Both postdialysis ICAM-1 and IL-1β levels in patients using cuprophane membrane (bioincompatible) showed insignificant higher levels than in those using polysulfone one (biocompatible). The percent increase in ICAM-1 level did not significantly differ in these two subgroups, while the percent increase in IL-1β level showed significantly higher value in those using bioincompatible membrane (108%) than that in those using biocompatible membrane (44%). No significant difference in the levels of either ICAM-1 or IL-1β were found between patients using acetate and bicarbonate dialysate. Conclusion: the bioincompatibility of the membrane is the important factor in the occurrence of the acute reaction during hemodialysis.
No takes yet. Share an insight, caveat, or question.
EL-Hefeni et al. (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: